# The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004, Article 3: Amendment of Schedule 3A to the principal Order


In Schedule 3A to the principal Order (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration), in the table—
(a) for the entry “Clavulanic acid”, in column 1 add “(as potassium clavulanate)” after “Clavulanic acid”;
(b) for the entry “Hydrocortisone acetate”, in column 2 add “or aural” after “External use”;
(c) for the entry “hyoscine butylbromide”, in column 2 omit “or transdermal” after “Parenteral”; and
(d) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2 insert, against that entry, the corresponding entry in column 2 below—
Column 1
Column 2
Hyoscine
Transdermal administration in palliative care

---
Source: https://www.legislation.gov.uk/uksi/2004/1189/article/3 (the official version)
Page: https://openlegislation.uk/prescription-only-medicines-human-use-amendment-no-2-order-2004/article-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.